Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janine Salter

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pathology|May 26, 2010
Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept studySuzanne Drury, Janine Salter, Frederick L Baehner, et al.
Breast Cancer Research : BCR|December 25, 2009
Who would have thought a single Ki67 measurement would predict long-term outcome?Mitch Dowsett, Roger A'Hern, Janine Salter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancerGiles Davies, Janine Salter, Margaret Hills, et al.
Cancer Research|October 16, 2003
Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft modelSimone Detre, Sharon Riddler, Janine Salter, et al.
Breast Cancer Research and Treatment|July 16, 2013
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC studyMaria Afentakis, Mitch Dowsett, Ivana Sestak, et al.
Journal of Clinical Pathology|July 31, 2010
Comparative validation of the SP6 antibody to Ki67 in breast cancerLila Zabaglo, Janine Salter, Helen Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2002
Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer preventionCatherine Harper-Wynne, Gillian Ross, Nigel Sacks, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Steroids|April 8, 2011
Predictive algorithms for adjuvant therapy: TransATACMitch Dowsett, Janine Salter, Lila Zabaglo, et al.
Breast Cancer Research and Treatment|July 2, 2008
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pathology|May 26, 2010
Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept studySuzanne Drury, Janine Salter, Frederick L Baehner, et al.
Breast Cancer Research : BCR|December 25, 2009
Who would have thought a single Ki67 measurement would predict long-term outcome?Mitch Dowsett, Roger A'Hern, Janine Salter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancerGiles Davies, Janine Salter, Margaret Hills, et al.
Cancer Research|October 16, 2003
Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft modelSimone Detre, Sharon Riddler, Janine Salter, et al.
Breast Cancer Research and Treatment|July 16, 2013
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC studyMaria Afentakis, Mitch Dowsett, Ivana Sestak, et al.
Journal of Clinical Pathology|July 31, 2010
Comparative validation of the SP6 antibody to Ki67 in breast cancerLila Zabaglo, Janine Salter, Helen Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2002
Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer preventionCatherine Harper-Wynne, Gillian Ross, Nigel Sacks, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Steroids|April 8, 2011
Predictive algorithms for adjuvant therapy: TransATACMitch Dowsett, Janine Salter, Lila Zabaglo, et al.
Breast Cancer Research and Treatment|July 2, 2008
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.
Pageof 4